At this year's American Academy of Ophthalmology meeting, the Ophthalmology Times team spoke with Megan Baldwin, MD, founder of Opthea Limited, about the company's ShORe and COAST clinical trials

At AAO 2023, Rich Small, CEO of Neurotech, spoke with our team about the company's development of encapsulated cell therapy, NT-501

At the 2023 AAO meeting, Paul Runge, MD, FACS, spoke with Ophthalmology Times about his time in Ukraine treating retinopathy of prematurity (ROP) and implementing the Norlase Lion laser at this year's American Academy of Ophthalmology meeting.

At this year's American Academy of Ophthalmology meeting, Anthony Wallace, BS, MBA, vice president and general manager of the surgical business at Bausch + Lomb North America, spoke with us about three exciting new launches

Ben Bergo, CEO of Visus Therapeutics, spoke with Ophthalmology Times about the BRIO-I study on presbyopia

Analysis of data from the European Union and the United States showed low-dose, preservative-free formulation of atropine is effective in slowing myopia progression in children

Bilateral distribution of the transgene seen with unilateral injection

In a study presented at the American Academy of Ophthalmology meeting, researchers asked practicing ophthalmologists to compare the ability of ChatGPT, Google Bard and Bing Chat in answering common patient questions

Peter K. Kaiser, MD, provides an overview of innovative therapies in development for patients with dry age-related macular degeneration.

Researchers at the University of Western Australia examined declining vision and increased risk of car accidents

Compared with other medical specialties, ophthalmologists typically experience lower burnout rates, explains Peter J. McDonnell, MD.

Investigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures

In a conversation with Ophthalmology Times, Mary Elizabeth Hartnett, MD, FACS, discussed her AAO presentation, focusing on the impact of blindness and vision loss on women in the United States

Esen K. Akpek, MD, discussed her presentation at this year's American Academy of Ophthalmology meeting, covering recent advancements in artificial corneas

Investigators sought to estimate the costs of treating GA with pegcetacoplan and to identify possible utility measures to compare treatments for GA

The ESCRS Symposium focused on innovations in the digital cataract and refractive surgery space

Kerrie Brady, president and chief executive officer of OcuTerra Therapeutics, shares progress in their Phase 2 DR:EAM Diabetic Retinopathy study, with promising results expected in Q1 2024 for their OTT166 eye drop treatment.

Data demonstrated that spontaneous macular hole closure and surgical treatment in paediatric patients appeared to be associated with comparable rates of closure and visual outcomes

The highlights from this year’s meeting, brought to you in conjunction with Modern Retina

Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution

There's much to do and see in San Francisco, where the American Academy of Ophthalmology (AAO) 2023 annual meeting will run from Friday 3 November through Monday 6 November

Data from the study, presented at the 2023 American Academy of Ophthalmology meeting in San Francisco, support the implantation of the LAL in eyes that had undergone a previous RK

The collection at the Truhlsen-Marmor Museum of the Eye includes more than 38,000 objects, including rare books, instruments and immersive educational materials.

Several companies including Kiora Pharmaceuticals, Adverum Biotechnologies and Aviceda Therapeutics, will share data at the 2023 meeting in San Francisco, California

Data indicated switching to SB15 from AFL maintained comparable clinical efficacy and safety, confirming biosimilarity between these agents

Academy’s program will take place in San Francisco, California, 3-6 November 2023, before returning to Chicago, Illinois in 2024

Case 1 highlights the potential for this treatment for patients with dry AMD with noted letter gains

The 23rd annual EURETINA Congress took place in Amsterdam, the Netherlands. We spoke with Arshad M. Khanani, MD, MA, FASRS, who provided an overview of his presentation, "Emerging therapies for exudative AMD"

Robyn Guymer, MBBS, PhD, Deputy Director, Centre for Eye Research Australia, and Professor of Surgery (Ophthalmology), University of Melbourne, Australia, discussed the study findings at the 23rd annual EURETINA Congress in Amsterdam, the Netherlands

We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial"